South Korea · The Block
Injective CEO Eric Chen expects US INJ ETFs to launch sooner than 2027
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
★ Tier-1 Source
Injective (INJ) co-founder and CEO Eric Chen said he expects U.S. exchange-traded funds tied to the Layer 1 network's native token INJ to launch before 2027.
Key facts
- Injective (INJ) co-founder and CEO Eric Chen said he expects U.S. exchange-traded funds tied to the Layer 1 network's native token INJ to launch before 2027
- I can't comment on the specific time, but I think 2027 is a little bit too far," Chen said Block at Korea Blockchain Week 2026
- According to the Securities and Exchange Commission's website, there are currently two ETF applications tied to INJ, the 21Shares Injective ETF and the Canary Staked INJ ETF — It is listed in the European Securities and Markets Authority's (ESMA) interim register, which was a disclosure step toward INJ's admission to trading in the EU
Summary
"I can't comment on the specific time, but I think 2027 is a little bit too far," Chen said Block at Korea Blockchain Week 2026. According to the Securities and Exchange Commission's website, there are currently two ETF applications tied to INJ, the 21Shares Injective ETF and the Canary Staked INJ ETF. Chen made the ETF comment amid a broader licensing push. "In terms of U.S. licensing, the reporter thinks transfer agent is the start.